137 related articles for article (PubMed ID: 31401851)
1. Polypharmacy among Older Individuals with COPD: Trends between 2000 and 2015 in Quebec, Canada.
Sirois C; Ouali A; Simard M
COPD; 2019 Aug; 16(3-4):234-239. PubMed ID: 31401851
[TBL] [Abstract][Full Text] [Related]
2. Use patterns of long-acting bronchodilators in routine COPD care: the OUTPUL study.
Di Martino M; Agabiti N; Bauleo L; Kirchmayer U; Cascini S; Pistelli R; Colamesta V; Patorno E; Pinnarelli L; Fusco D; Perucci CA; Davoli M;
COPD; 2014 Aug; 11(4):414-23. PubMed ID: 24090036
[TBL] [Abstract][Full Text] [Related]
3. Incidence, Predictors, and Clinical Implications of Discontinuing Therapy with Inhaled Long-Acting Bronchodilators among Patients with Chronic Obstructive Pulmonary Disease.
Arfè A; Nicotra F; Cerveri I; de Marco R; Vaghi A; Merlino L; Corrao G
COPD; 2016 Oct; 13(5):540-6. PubMed ID: 26934569
[TBL] [Abstract][Full Text] [Related]
4. Poor adherence to chronic obstructive pulmonary disease medications in primary care: Role of age, disease burden and polypharmacy.
Vetrano DL; Bianchini E; Onder G; Cricelli I; Cricelli C; Bernabei R; Bettoncelli G; Lapi F
Geriatr Gerontol Int; 2017 Dec; 17(12):2500-2506. PubMed ID: 28656664
[TBL] [Abstract][Full Text] [Related]
5. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
[TBL] [Abstract][Full Text] [Related]
6. Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada.
Tavakoli H; Johnson KM; FitzGerald JM; Sin DD; Gershon AS; Kendzerska T; Sadatsafavi M
Int J Chron Obstruct Pulmon Dis; 2019; 14():2003-2013. PubMed ID: 31564848
[TBL] [Abstract][Full Text] [Related]
7. Seventeen-Year Nationwide Trends in Use of Long-acting Bronchodilators and Inhaled Corticosteroids among Adults - A Danish Drug Utilization Study.
Reilev M; Pottegård A; Davidsen JR; Rasmussen L; Søndergaard J; Laursen CB; Henriksen DP
Basic Clin Pharmacol Toxicol; 2018 Jul; 123(1):58-64. PubMed ID: 29417739
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of early medication use for COPD: a population-based cohort study.
Falk J; Dik N; Bugden S
Int J Chron Obstruct Pulmon Dis; 2016; 11():3101-3108. PubMed ID: 27994449
[TBL] [Abstract][Full Text] [Related]
9. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
Gershon AS; Campitelli MA; Croxford R; Stanbrook MB; To T; Upshur R; Stephenson AL; Stukel TA
JAMA; 2014 Sep; 312(11):1114-21. PubMed ID: 25226477
[TBL] [Abstract][Full Text] [Related]
10. The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy.
Di Martino M; Agabiti N; Cascini S; Kirchmayer U; Bauleo L; Fusco D; Belleudi V; Pinnarelli L; Voci C; Patorno E; Pistelli R; Davoli M;
COPD; 2016 Jun; 13(3):293-302. PubMed ID: 26514912
[TBL] [Abstract][Full Text] [Related]
11. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
Blais L; Forget A; Ramachandran S
Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
[TBL] [Abstract][Full Text] [Related]
12. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic Status, Sex, Age and Access to Medications for COPD in Ontario, Canada.
Gershon A; Campitelli MA; Hwee J; Croxford R; To T; Stanbrook MB; Upshur R; Stephenson A; Stukel TA
COPD; 2015; 12(6):668-79. PubMed ID: 26244774
[TBL] [Abstract][Full Text] [Related]
14. Long-term pharmacologic management of patients with chronic obstructive pulmonary disease.
Briggs DD; Doherty DE
Clin Cornerstone; 2004; Suppl 2():S17-28. PubMed ID: 15500180
[TBL] [Abstract][Full Text] [Related]
15. Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients.
Contoli M; Campo G; Pavasini R; Marchi I; Pauletti A; Balla C; Spanevello A; Ferrari R; Papi A
Eur J Intern Med; 2018 Jan; 47():82-86. PubMed ID: 28821412
[TBL] [Abstract][Full Text] [Related]
16. The delicate choice of optimal basic therapy for multimorbid older adults: A cross-sectional survey.
Sirois C; Lunghi C; Laroche ML; Maheux A; Frini A
Res Social Adm Pharm; 2019 Jun; 15(6):761-766. PubMed ID: 30249377
[TBL] [Abstract][Full Text] [Related]
17. Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients.
Ismaila A; Corriveau D; Vaillancourt J; Parsons D; Dalal A; Su Z; Sampalis JS
Curr Med Res Opin; 2014 Jul; 30(7):1427-36. PubMed ID: 24666181
[TBL] [Abstract][Full Text] [Related]
18. Optimizing Drug Therapies in Patients with COPD in the US Nursing Home Setting.
Pleasants RA; Radlowski PA; Davidson HE
Drugs Aging; 2019 Aug; 36(8):733-745. PubMed ID: 31172422
[TBL] [Abstract][Full Text] [Related]
19. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
[TBL] [Abstract][Full Text] [Related]
20. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
Lipworth B; Skinner D; Devereux G; Thomas V; Ling Zhi Jie J; Martin J; Carter V; Price DB
Heart; 2016 Dec; 102(23):1909-1914. PubMed ID: 27380949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
